Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
Abstract FOXM1 transcription factor is an oncogene and a master regulator of chemoresistance in multiple cancers. Pharmacological inhibition of FOXM1 is a promising approach but has proven to be challenging. We performed a network-centric transcriptomic analysis to identify a novel compound STL42794...
Main Authors: | Mikhail S. Chesnokov, Marianna Halasi, Soheila Borhani, Zarema Arbieva, Binal N. Shah, Rick Oerlemans, Irum Khan, Carlos J. Camacho, Andrei L. Gartel |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03978-0 |
Similar Items
-
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
by: Mikhail S Chesnokov, et al.
Published: (2021-07-01) -
FoxM1 is a general target for proteasome inhibitors.
by: Uppoor G Bhat, et al.
Published: (2009-08-01) -
Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.
by: Marianna Halasi, et al.
Published: (2012-01-01) -
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
by: Uppoor G Bhat, et al.
Published: (2009-01-01) -
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
by: I. Khan, et al.
Published: (2023-08-01)